← Every company

Supernus Pharmaceuticals Inc SEC Filings

What Supernus Pharmaceuticals Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.

SUPN overview →
Filings on file
188
since Nov 10, 2016
Warning signs
12
latest Mar 2, 2023
Last results
Aug 3, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834

Newest first

Each label is a form type or an 8-K item as filed; each row links to the filing.

FiledWhat it reportsDocument
Mar 2, 2023
Late filing notice
NT 10-K
Read ↗
May 10, 2022
Late filing notice
NT 10-Q
Read ↗
Mar 21, 2022
Delisting notice or listing transfer
8-K
Read ↗
Mar 1, 2022
Late filing notice
NT 10-K
Read ↗
Mar 1, 2021
Late filing notice
NT 10-K
Read ↗
Aug 11, 2020
Late filing notice
NT 10-Q
Read ↗
May 12, 2020
Late filing notice
NT 10-Q
Read ↗
Jan 16, 2018
Delisting notice or listing transferExecutive or director change
8-K
Read ↗
Mar 1, 2017
Late filing notice
NT 10-K
Read ↗
Nov 18, 2016
Delisting notice or listing transfer
8-K
Read ↗
Nov 14, 2016
Earlier accounts withdrawn
8-K
Read ↗
Nov 10, 2016
Late filing notice
NT 10-Q
Read ↗

Source: Supernus Pharmaceuticals Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.

More on SUPN

Related datasets